Sri Lanka, Nov. 18 -- The World Health Organization (WHO) has announced the start of a programme to prequalify human insulin to increase treatment for diabetes in low-and middle-income countries.
About 65 million people with type 2 diabetes need insulin, but only half of them are able to access it, largely due to high prices. All people with type 1 diabetes need insulin to survive.
In recent years, a great number of biotherapeutic products (BTPs) have demonstrated success in treating many life-threatening chronic diseases. In May 2014, the World Health Assembly (WHA) adopted Resolution WHA67.21 on "Access to biotherapeutic products, including similar biotherapeutic products, and ensuring their quality, safety and efficacy".
BTPs are high...